Data Availability
All data referred in the manuscript are available on resonable request to Fu-Sheng Wang at fswang302@163.com. Additional information Who can access the data: researchers whose proposed use of the data has been approved Types of analysis: Such requests are at the Academic Committee's discretion and dependent on the nature of the request, the merit of the research proposed, availability of the data and the intended use of the data. Mechanisms of data availability: After approval from the Academic Committee, this trial data can be shared with qualifying researchers who submit a proposal with a valuable research question. A contract should be signed. Any additional restrictions: NA.
Posted October 21, 2020.
Treatment with human umbilical cord-derived mesenchymal stem cells for COVID-19 patients with lung damage: a randomised, double-blind, placebo-controlled phase 2 trial
